EVI2B Is a New Prognostic Biomarker in Metastatic Melanoma with IFNgamma Associated Immune Infiltration.
Satoru YonekuraKousuke UedaPublished in: Cancers (2021)
EVI2B is a novel prognostic biomarker with IFN-γ associated immune infiltration in metastatic melanoma.
Keyphrases